Media Alert—Jan. 5 Virtual Press Briefing
Keck Medicine of USCKeck Medicine of USC to provide COVID-19 update on staff vaccinations; future patient and community efforts
Keck Medicine of USC to provide COVID-19 update on staff vaccinations; future patient and community efforts
Dr. Kathleen Neuzil, MD, MPH, FIDSA, the Myron M. Levine, MD, DTPH, Professor in Vaccinology and Director of the University of Maryland School of Medicine’s (UMSOM)’s Center for Vaccine Development and Global Health (CVD), has been named this year’s “Marylander of the Year” by the Baltimore Sun.
Three thousand doses of Moderna’s COVID-19 vaccine arrived at the Texas Tech Physicians of El Paso Alberta, Kenworthy and Transmountain clinics on Wednesday, Dec. 23.
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network which has treated more COVID-19 patients than any other health system in the state, is now enrolling individuals in the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 COVID-19 vaccine trial.
Around a third of the world's population carries Toxoplasma gondii, a parasite that puts people with a weakened immune system at risk and can trigger malformations in the womb.
When Joni Stokx, RN, heard that the COVID-19 vaccine was coming, it brought her to tears. A nurse at Cedars-Sinai Marina del Rey Hospital, she's been caring for COVID-19 patients for 10 months. While she and her co-workers wear all the recommended personal protective equipment (PPE) and take lots of precautions, getting the vaccine will help her feel safer.
A little slice of life at a vaccination clinic at UW Medicine in Seattle.
The American Association of Nurse Anesthetists (AANA) Board of Directors approved a position statement recommending that Certified Registered Nurse Anesthetists (CRNAs) and student registered nurse anesthetists educate themselves to make an informed decision about receiving the vaccine and ensure that their healthcare administrators are aware of the important role CRNAs have in patient care, especially during the pandemic.
FLCCC physicians: “Ivermectin will remain a potent anti-viral even against mutant strain.”
Policies to contain the Covid-19 pandemic require widespread cooperation in order to be successful.
Hours after the United Kingdom raised alarm about the new variant of the coronavirus, which causes COVID-19, social media, including Twitter, is brimming with theories on the timing of this news. Many people have remarked that the timing of this news coming on the heels of the new vaccines is suspicious.
The American Association of Critical-Care Nurses has released a statement strongly recommending that nurses be vaccinated against COVID-19. In the statement, the organization addresses the nuanced sense of pride and anxiety felt by nurses and other healthcare professionals who have been given top priority to receive the first COVID-19 vaccines.
Royalty Pharma today announced a charitable contribution by Royalty Pharma in the amount of $1,000,000 to Mount Sinai Health System.
LifeBridge Health has begun to administer the COVID-19 vaccine to front-line healthcare workers. The first doses of the newly approved Pfizer COVID vaccine arrived at LifeBridge Health on December 17 with 24 team members receiving the vaccine that afternoon at Sinai Hospital.
An opinion piece published today online in BMJ by Nina Schwalbe in the Heilbrunn Department of Population and Family Health at Columbia Mailman School of Public Health, calls for a national vaccine strategy now that COVID-19 vaccines are available.
University of Minnesota Twin Cities researchers have created a new polymer to deliver DNA and RNA-based therapies for diseases. For the first time in the industry, the researchers were able to see exactly how polymers interact with human cells when delivering medicines into the body. This discovery opens the door for more widespread use of polymers in applications like gene therapy and vaccine development.
As the United States begins rolling out coronavirus vaccines, many people, especially those in the Black community, are still hesitant to participate when it becomes widely available. Valerie Fitzhugh, a Rutgers doctor discusses why she chose to participate in a coronavirus vaccine trial as a Black woman, wife, and mother of two children and encourages more people, particularly minorities, to be vaccinated.
University of Miami Miller School of Medicine researchers have begun recruiting for a study looking at the impact of the COVID-19 vaccine on male fertility. The Miller School is the first institution studying the effects on sperm of men who receive the vaccine, according to the study’s principal investigator, Ranjith Ramasamy, M.D., associate professor and director of reproductive urology.
First UChicago Medicine employees vaccinated against SARS-CoV-2; Paves way for thousands more to be scheduled over next several weeks
The first wave of Cedars-Sinai staff members are receiving the much-anticipated COVID-19 vaccine Thursday morning, an occasion that is bringing hope and relief to those who have fought on the medical frontline for nearly a year against the deadly illness.
Today, Hackensack Meridian Mountainside Medical Center began administering the first Pfizer COVID-19 vaccines to frontline team members. Mountainside Medical Center will administer 975 vaccinations from the first shipment of vaccines delivered to the hospital. Steven Sokolowski, Respiratory Therapist marked the historic occasion by receiving the first dose.
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, is pleased to announce that more than $145,000 has already been granted by several leading New Jersey headquartered banks and affiliated foundations, including: OceanFirst Bank, Peapack-Gladstone Bank, Manasquan Bank and Valley Bank.
The Forum of International Respiratory Societies (FIRS), an organization comprised of the world's leading international respiratory societies, including founding member the American Thoracic Society, calls for urgent access to affordable COVID-19 vaccines globally.
Vaccines are in the news again – along with misinformation about their safety. We replace the common myths with truths about the safety and benefits of vaccination in this week’s Medical Minute.
As the biggest vaccination effort in U.S. history gets underway, several states may not have enough facilities in some areas to administer the COVID-19 vaccine to all residents who want it, according to a new analysis from the University of Pittsburgh School of Pharmacy and the nonprofit West Health.
Greg Whitcher, M.D., a resident in the Department of Emergency Medicine at Texas Tech University Health Sciences Center El Paso, explains how the COVID-19 vaccine works.
Key Takeaways: • Memorial Hermann is proud to be part of history in the making, as the first health systems across the country begin receiving and administering the Pfizer COVID-19 vaccine to their frontline healthcare workers • Memorial Hermann’s first vaccine was given to Robert Luckey, a nurse in the COVID ICU at Memorial Hermann-Texas Medical Center • To date, Memorial Hermann has treated more than 12,000 COVID-19 positive patients in its hospitals, more than any other health system in the Greater Houston area • The system expects to receive 16,575 doses of the Pfizer vaccine in the first allotment, more than any other health system in the Greater Houston area • It’s important that everyone continues practicing the three “W’s”: wearing a mask, watching social distance and washing hands frequently
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
The FDA granted emergency use authorization today for an innovative COVID-19 viral antigen test developed with support from NIH’s RADx Initiative.
Frontline healthcare workers at Cedars-Sinai and the broader Los Angeles community saw light at the end of the pandemic tunnel as the much-anticipated COVID-19 vaccine arrived at the academic medical center Tuesday. Downloadable video available.
With the first round of COVID-19 vaccines being deployed to states across the country, the American Society of Anesthesiologists (ASA) advises that anesthesia professionals, and other frontline health care workers, be prioritized to receive early access to the COVID-19 vaccination given their high risk of exposure to the virus in operating rooms, labor and delivery suites, procedural areas, emergency rooms and critical care units.
Vaccines that prevent infection by SARS-CoV-2, the virus that causes COVID-19, are being rolled out around the world. Below are five things about vaccine science of which you may be unaware. Additionally, here is a video about how vaccines are determined safe.
A team of scientists from The Wistar Institute, INOVIO, AstraZeneca, the Perelman School of Medicine at the University of Pennsylvania, and Indiana University has received a $37.6 million award over two years from the Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) for rapid preclinical development and translational studies of DNA-encoded monoclonal antibodies (DMAbs) as countermeasures for COVID-19.
Join us for a virtual press conference as Keck Medicine of USC experts discuss how the health system is handling the receipt and distribution of vaccines the day before vaccinations begin.
National efforts to develop a coronavirus disease 2019 (COVID-19) vaccine at “warp speed” will likely yield a safe and effective vaccine by early 2021. However, this important milestone is only the first step in an equally important challenge: getting a majority of the U.S. public vaccinated.
University Health Network (UHN) today gave the first COVID-19 vaccine in Canada. This landmark event signals a potential turning point in the pandemic and underlines the value of science and worldwide cooperation.
At the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo, a series of late-breaking sessions will delve into the newest research on the rapidly evolving COVID-19 pandemic. Highlights of these sessions include a talk that will provide expert insight into the many coronavirus vaccines currently in development, as well as an expert presentation on coronavirus immunity and antibody testing.
The availability of COVID-19 vaccines will not necessarily result in people getting fully vaccinated, because the first vaccines require a second dose within a few weeks to get full protection. Mark Fendrick, M.D., has studied barriers to preventive health services and offers suggestions based on past research for how to ensure full vaccination.
New research by scientists at the University of Chicago suggests a person’s antibody response to influenza viruses is dramatically shaped by their pre-existing immunity, and that the quality of this response differs in individuals who are vaccinated or naturally infected. Their results highlight the importance of receiving the annual flu vaccine to induce the most protective immune response.
A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health.
GreenMedInfo, an alternative health website that has published articles claiming vaccines cause autism, published an article on December 6th warning about the adverse side effects of the coronavirus vaccines, including death. We rate this article as mostly false and misleading.
As the U.S. authorizes distribution of the COVID vaccines from Pfizer and Moderna, here’s what you need to know about the vaccines — how they work, the doses required, their effectiveness and more.